Table 3. Multiple regression survival analysis for stage III, IV patients with CCC.

Variables	Hazard ratio	95% confidence interval	P
Age (years)			0.96
<54	1
>55	0.99	0.60; 1.61
PS			0.67
0	1
1,2	1.06	0.79; 1.43
FIGO stage			0.22
III	1
IV	1.47	0.80; 2.70
Residual tumour			0.02
None	1
<1 cm	2.23	0.89; 5.54
>1 cm	3.17	1.68; 6.00
Chemotherapy			0.24
CAPa	1
Paclitaxel+platinum	0.56	0.48; 1.88
Others	0.95	0.32; 1.22

^aCAP, cyclophosphamide+doxorubicin+cisplatin.